ConductScience.org, home

Paper21272136

High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease.

Wang TY and 6 others. Nephrology (Carlton), 2011. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease. Papers, record 21272136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21272136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease.
PubMed
Journal
Nephrology (Carlton)
PubMed
Year
2011
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2014-07-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang TYTsung-Yang
2Hu CJChia-Jung
3Kuo CWChin-Wei
4Chen YYu
5Lin JLJa-Liang
6Yang CWChih-Wei
7Yen THTzung-Hai

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Transitional CellMajor topic
Kidney Failure, ChronicMajor topic
Urologic NeoplasmsMajor topic
Aged
Female
Humans
Incidence
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Recurrence, Local
Peritoneal Dialysis
Regression Analysis
Renal Dialysis
Risk Factors
Taiwan
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
39659915Recurrence risk of erythropoiesis-stimulating agents on early-stage urothelial carcinoma in patients with end stage renal disease.Am J Cancer Res2024https://conductscience.org/library/papers/39659915PubMed
39090146No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy.Sci Rep2024https://conductscience.org/library/papers/39090146PubMed
38593276NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas.Kaohsiung J Med Sci2024https://conductscience.org/library/papers/38593276PubMed
34829313Treatment Strategy for Dialysis Patient with Urothelial Carcinoma.Diagnostics (Basel)2021https://conductscience.org/library/papers/34829313PubMed
31261684Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.Int J Mol Sci2019https://conductscience.org/library/papers/31261684PubMed
29069858Hepatocellular carcinoma in hemodialysis patients.Oncotarget2017https://conductscience.org/library/papers/29069858PubMed
27275607Oral Tori in Chronic Peritoneal Dialysis Patients.PLoS One2016https://conductscience.org/library/papers/27275607PubMed
27057873Chronic Kidney Disease is Associated With Upper Tract Urothelial Carcinoma: A Nationwide Population-Based Cohort Study in Taiwan.Medicine (Baltimore)2016https://conductscience.org/library/papers/27057873PubMed
26220096Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.Clin Transl Oncol2016https://conductscience.org/library/papers/26220096PubMed
25918724Oral tori in chronic hemodialysis patients.Biomed Res Int2015https://conductscience.org/library/papers/25918724PubMed
25431765Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.Biomed Res Int2014https://conductscience.org/library/papers/25431765PubMed
25177705Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.Biomed Res Int2014https://conductscience.org/library/papers/25177705PubMed
23674847Hepatocellular carcinoma in patients with chronic kidney disease.World J Gastroenterol2013https://conductscience.org/library/papers/23674847PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21272136

GET https://conductscience.org/api/papers/v1/21272136/authors